Navigation Links
Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
Date:10/24/2013

8 Goodwill 621.3 644.5 Other intangible assets, net 2,976.0 2,388.1 Deferred tax asset 40.4 46.5 Other non-current assets 34.5 31.5 Total assets 8,387.9 7,317.2 LIABILITIES AND EQUITY Current liabilities: Accounts payable and accrued expenses 1,581.6 1,501.5 Convertible bonds 1,100.0 - Other current liabilities 163.2 144.1 Total current liabilities 2,844.8 1,645.6 Non-current liabilities: Convertible bonds - 1,100.0 Deferred tax liability 722.0 520.8 Other non-current liabilities 652.3 241.6 Total liabilities 4,219.1 3,508.0 Equity: Common stock of 5p par value; 1,000 million shares authorized; and 562.9 million shares issued and outstanding (2012: 1,000 million shares authorized; and 562.5 million shares issued and outstanding) 55.8 55.7 Additional paid-in capital 3,045.6 2,981.5 Treasury stock: 14.5 million shares (2012: 10.7 million) (466.6) (310.4) Accumulated other comprehensive income 101.3 86.9 Retained earnings 1,432.7 995.5 Total equity 4,168.8 3,809.2 Total liabilities and equity 8,387.9 7,317.2

Unaudited US GAAP results for the three months and nine months to September 30, 2013
Consolidated Statements of Income

9 months 9 months 3 months to 3 months to to to September September September 30, September 30, 30, 30, 2013 2012 2013 2012 $M $M $M $M Revenues: Product sales 1,194.9 1,054.5 3,541.8 3,309.1 Royalties 37.6 41.8 112.4 154.4 Other revenues 4.1 4.1 18.8 16.5 Total revenues 1,236.6 1,100.4 3,673.0 3,480.0 Costs and expenses: Cost of product sales 197.1 167.9 528.7 478.8 R&D(1) 229.1 224.7 713.4 683.6 SG&A(1) 441.1 437.4 1,337.4 1,448.4 Goodwill impairment charge - - 198.9 - Gain on sale of product rights (3.6) (5.7) (14.6) (16.5) Reorganization costs 13.7 - 57.6 - Integration and acquisition costs 18.4 2.7 39.9 15.1 Total operating expenses 895.8 827.0 2,861.3 2,609.4 Operating income 340.8 273.4 811.7 870.6 Interest income 0.4 0.9 1.6 2.3 Interest expense (9.0) (9.2) (27.0) (29.0) Other income/(expense), net
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
2. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
3. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
4. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
5. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
6. Shire Changes its NASDAQ Ticker Symbol to SHPG
7. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
8. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
9. Shire Reaches Agreement in Principle With U.S. Government
10. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
11. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014   TRU-D SmartUVC LLC and its UK ... automated disinfection robot, TRU-D SmartUVC, at FIS 2014 in ... to 26 at Stand 23. The conference, hosted ... Kingdom,s largest infection-related event of its kind and ... of the leading events of its type throughout the world. ...
(Date:11/21/2014)... November 20, 2014 The ... Chassis, Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, ... (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast ... market drivers, threats, opportunities, and challenges. , ... figures spread through 185 pages and in-depth ...
(Date:11/21/2014)... 2014 Deep Research Report on ... research report on the transformer market. The report ... and industry chain structure as well as industry ... including China’s domestic market as well as global ... analysis. The report also covers information on policy, ...
(Date:11/18/2014)... , Nov. 18, 2014 Cord Blood ... sponsor of the 10th Annual World Stem Cell Summit, the ... stakeholders. The 2014 World Stem Cell Summit will be held ... Antonio, Texas . The World ... development of lifesaving cures and therapies, convening the most prominent ...
Breaking Biology Technology:TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 2TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3
... genetics (Nasdaq: DCGN ) announced today that it ... institution, pursuant to which NBI has purchased deCODE,s auction rate ... the agreement, deCODE has the call option to require NBI ... time prior to December 31, 2009. NBI has the put ...
... MISSISSAUGA, ON, Jan. 20 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: ... a Nasdaq Staff Deficiency Letter on January 13, 2009, ... director requirement as set forth in Nasdaq Marketplace Rule ... the resignation of a Director, which was announced publicly ...
... Inc. (Nasdaq: NLTX ), today announced that ... natriuretic peptide franchise, including CD-NP which is in Phase ... is a pre-clinical compound. Nile will suspend the further ... compound to Dr. Cesare Casagrande. "We are disappointed that ...
Cached Biology Technology:deCODE Sells Auction Rate Securities 2deCODE Sells Auction Rate Securities 3Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1) 2Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 2Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 3Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 4
(Date:11/7/2014)... -- Leading Biometric companies aim to provide consumers ... transactions.  Companies in focus today are: NXT-ID, Inc. (NASDAQ: ... ), Google Inc. (NASDAQ: GOOG ), Microsoft Corporation ... EBAY ) and MasterCard Inc. (NYSE: MA) NXT-ID, ... authentication company focused on the growing mobile commerce is pleased ...
(Date:11/6/2014)... cancer deaths occur because of metastasis, yet progress ... been slow. , "It,s been particularly challenging to ... Gujral, research fellow in systems biology at Harvard ... detected until after they,ve already metastasized." , Gujral ... that should help researchers better understand how metastasis ...
(Date:11/6/2014)... Medicine, Inc, a Baltimore-based bioinformatics company focused on ... a research collaboration with the international leader in ... CSBR). , "There are many companies utilizing advances ... TumorGraft technology is unique in a way that ... vast amounts of valuable data. Our bioinformatic analysis ...
Breaking Biology News(10 mins):Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6Migration negation 2Migration negation 3Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
... nurses, and firefighters essential during a severe pandemic influenza ... and utility workers. That,s the conclusion of a Johns ... of Biosecurity and Bioterrorism . The report, led ... for the Johns Hopkins Berman Institute of Bioethics, provides ...
... neuroblastoma and melanoma developed by scientists and ... collaboration with investigators from the University of Iowa is ... to new research published in the October edition of ... vaccine uses the tumor,s own protein to induce an ...
... fossils revealed a herd of dinosaurs that perished in ... are characterized by a bony frill on the back ... had large bony structures above their nose and eyes ... structures probably supported horns of keratin. According to ...
Cached Biology News:Rethinking who should be considered 'essential' during a pandemic flu outbreak 2Children's National researchers develop novel anti-tumor vaccine 2A new dinosaur species, Pachyrhinosaur lakustai, unveiled from Pipestone Creek, Alberta, Canada 2
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
... Desselberger (1995) • This book is ... classical and molecular techniques currently used ... and analysis of virus-specific antibodies and ... presented covering immunoassays, blotting and hybridization ...
Performance, mycoplasma, virus, and endotoxin tested. Collected from calves 14 days old or less...
Bovine Serum...
Biology Products: